A concentrated phosphatidylcholine supplement that delivers high-potency choline for brain and liver support. Feeds your brain's memory circuits and helps your liver handle fat processing
Reviewed March 2026
Source: Blusztajn et al. 2017 Nutrients review; Zeisel & da Costa 2009 Nutr Rev.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Phosphatidylcholine 75% has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Phosphatidylcholine is hydrolysed by phospholipases to release free choline, and free choline is re-esterified back into phosphatidylcholine through the Kennedy pathway. The two feed one interchangeable choline pool.
Choline is oxidised to betaine, which donates a methyl group to remethylate homocysteine to methionine. Supplying betaine spares dietary choline for membrane phospholipid synthesis instead of methyl donation.
The PEMT pathway builds phosphatidylcholine by adding three methyl groups from SAM-e to phosphatidylethanolamine. SAM-e availability therefore sets how much phosphatidylcholine the liver can make without dietary choline.
Folate-dependent remethylation of homocysteine and betaine-dependent remethylation are parallel routes to methionine. Adequate methylfolate lowers the call on choline-derived betaine and leaves more choline for phospholipid use.
Methionine synthase needs B12 to move the methyl group from folate onto homocysteine. When that route is limited, more of the load falls on the choline-betaine arm that phosphatidylcholine supplies.
B6 as pyridoxal phosphate runs the transsulfuration step that clears homocysteine down the cysteine route. It works alongside the choline-betaine and folate arms in the same methylation loop.
Choline released from phosphatidylcholine is acetylated to acetylcholine using acetyl-CoA, and pantothenic acid is the backbone of coenzyme A. Both halves of that reaction have to be present for normal acetylcholine formation.
Alpha-GPC is the deacylated form of phosphatidylcholine and is converted back and forth within the same pathway. Both raise the free choline available for phospholipid and acetylcholine synthesis.
CDP-choline is the activated intermediate that donates phosphocholine to diacylglycerol in the final step of phosphatidylcholine synthesis. Supplying the intermediate and the finished phospholipid feeds the same route at two points.
Serine base exchange builds phosphatidylserine from existing phosphatidylcholine or ethanolamine phospholipids, and decarboxylation runs the traffic back the other way. They are members of one interconverting membrane pool.
Phosphatidylcholine forms a lipid complex with curcuminoids that disperses into mixed micelles instead of staying undissolved. This phytosome approach is the standard way poorly soluble botanicals are made absorbable.
Silybin complexed with phosphatidylcholine partitions into lipid phases far more readily than free silybin. The phospholipid is the carrier that makes the flavonolignan absorbable.
CoQ10 is a large lipophilic quinone whose uptake depends on being carried in a lipid or micellar phase. Phospholipid emulsification keeps it dispersed and improves its entry into mixed micelles.
Phosphatidylcholine forms the outer shell of chylomicrons and lipoproteins that carry long-chain fatty acids in circulation, and it is also the phospholipid form in which DHA is delivered to tissue. Both the carrier and the cargo come from the same lipid handling system.
Tocopherols need a lipid phase and bile-mediated micelles to be taken up. Phospholipid emulsifiers disperse them and support micelle formation during digestion.
Lecithin is the crude phospholipid mixture from which a 75 percent phosphatidylcholine fraction is concentrated, and it still carries phosphatidylethanolamine and phosphatidylinositol. Using both gives the concentrated fraction plus the accompanying phospholipid classes.
Phosphatidylcholine carries choline esterified into a phospholipid backbone, and phospholipase activity in the gut and tissues frees that choline for use. Free choline taken alongside it feeds the same pool from the other end, entering the Kennedy pathway as phosphocholine. The two are not interchangeable in kinetics: free choline appears in plasma faster, the phospholipid form travels with lipid transport.
Three sequential methyl transfers convert phosphatidylethanolamine into phosphatidylcholine, and every one of them spends an S-adenosylmethionine molecule made from methionine. When dietary phosphatidylcholine is plentiful this endogenous route is used less, which spares methyl groups for other acceptors. The relationship runs both ways and is a textbook feature of hepatic one-carbon handling.
Docosahexaenoic acid is carried in the body largely at the sn-2 position of phosphatidylcholine and phosphatidylethanolamine, so the phospholipid pool is the vehicle for it rather than a separate compartment. Supplying phosphatidylcholine expands the carrier pool that long-chain omega-3 fatty acids are esterified into. A candidate trial of EPA plus DHA reported shifts in fatty acid concentrations across plasma lipid pools, which is a marker measurement and not a clinical outcome.
Eicosapentaenoic acid moves between triacylglycerol, cholesteryl ester and phospholipid pools, and the phosphatidylcholine fraction is one of its main plasma carriers. Adding phosphatidylcholine supplies more of that carrier structure. What is measured in this pairing is fatty acid distribution across lipid fractions, a marker.
A large share of the EPA and DHA in krill oil is esterified to phosphatidylcholine rather than to triglyceride, so the two ingredients overlap in what they deliver. Stacking them raises total phospholipid intake, which is worth knowing when a formula already counts on krill oil for its phospholipid content. This is a compositional overlap, not a demonstrated additive effect on any endpoint.
Phosphatidylcholine from oilseed lecithin carries linoleic acid at high proportion, so a dose of it is also a dose of that fatty acid. Formulators tracking total polyunsaturated load should count both. It also explains why oxidation control matters in these concentrates.
Crude lecithin is a mixture of phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and residual oil, and the 75% material is the phosphatidylcholine fraction pulled out of it. Taking both means taking the concentrate plus the other phospholipids that were left behind. Neither is a substitute for the other on a gram-for-gram phosphatidylcholine basis.
Phosphatidylcholine has to be dispersed into mixed micelles before pancreatic phospholipase A2 can cleave it to lysophosphatidylcholine and a free fatty acid for uptake. Bile salts are what create that dispersion. People with sluggish bile flow handle phospholipid loads differently, which is why the pairing shows up in digestive formulas.
Absorption of phosphatidylcholine depends on enzymatic cleavage at the sn-2 position, producing lysophosphatidylcholine that the enterocyte takes up and re-acylates. Supplemental pancreatic enzyme preparations carry phospholipase alongside lipase. The step is obligatory, so anything limiting it limits how much intact phospholipid gets across.
Broad pancreatic enzyme blends contain the phospholipase activity that phosphatidylcholine absorption requires, plus lipase for the oil carrier the concentrate is usually suspended in. The pairing is about processing the delivered form, not about changing what the phospholipid does afterwards.
Gut bacteria act on dietary phosphatidylcholine and its choline headgroup, and prebiotic substrate changes which organisms are doing that. A candidate study in animals reported shifts in cecal microbiota alongside phospholipid and aromatic amino acid metabolites after galacto-oligosaccharide supplementation. That is a non-human, metabolite-level observation and does not establish anything about a person taking both.
Choline released from phosphatidylcholine is oxidised to betaine, which donates a methyl group to homocysteine to regenerate methionine. Supplying betaine directly reduces the demand on that oxidative route and leaves more choline available for phospholipid synthesis and acetylcholine. The hydrochloride salt form also lowers gastric pH, a separate and unrelated effect.
Turning choline into betaine runs through a flavin-dependent dehydrogenase in the mitochondrion. Riboflavin status therefore sits upstream of how choline liberated from phosphatidylcholine is partitioned between the methyl pool and phospholipid resynthesis. This is a cofactor relationship, not a demonstrated combined effect.
Talk to a doctor before taking Phosphatidylcholine 75% if any of these apply to you: Fishy body odor possible at high doses, Source (soy vs sunflower) matters for allergy concerns, May interact with anticholinergic drugs. These are flags to check first, not effects Phosphatidylcholine 75% is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 6,667 we read for Phosphatidylcholine 75%. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.